Ratings by Baird (Brian Skorney)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/22/2026 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2026 | Nurix | NRIX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/1/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/18/2026 | Alto Neuroscience | ANRO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2026 | Alto Neuroscience | ANRO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/27/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/6/2026 | Soleno Therapeutics Inc. | SLNO | Downgrade | Neutral (Outperform) |
39.49 (53.01) |
34.24% | Details | |
| 4/6/2026 | Neurocrine Bio. | NBIX | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/30/2026 | Alumis Inc | ALMS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/18/2026 | Alto Neuroscience | ANRO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/9/2026 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2026 | Sarepta Therapeutics | SRPT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2026 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2026 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/9/2026 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/2/2026 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 1/30/2026 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 1/29/2026 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/26/2026 | Sarepta Therapeutics | SRPT | Maintain | Neutral (N/A) |
|
Details | ||
| 1/13/2026 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Benitec BioPharma | BNTC | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2026 | Enanta Pharmaceuticals | ENTA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/6/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | Underperform (N/A) |
|
Details | ||
| 1/6/2026 | Alumis Inc | ALMS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/5/2026 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/12/2025 | Applied Therapeutics | APLT | Downgrade | Neutral (Outperform) |
0.22 (0.10) |
-54.55% | Details | |
| 12/8/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2025 | Alto Neuroscience | ANRO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Amgen | AMGN | Maintain | Underperform (N/A) |
|
Details | ||
| 11/4/2025 | Sarepta Therapeutics | SRPT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2025 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2025 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 10/20/2025 | Alto Neuroscience | ANRO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/16/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/26/2025 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 8/7/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2025 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/18/2025 | Sarepta Therapeutics | SRPT | Downgrade | Neutral (Outperform) |
21.97 (16.02) |
-27.08% | Details | |
| 7/17/2025 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 7/10/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/18/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2025 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/30/2025 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2025 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2025 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2025 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/28/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/25/2025 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/27/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/20/2025 | Alumis Inc | ALMS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2025 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2025 | Mirum Pharamceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2025 | Alumis Inc | ALMS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2025 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 1/31/2025 | Vertex | VRTX | Maintain | Underperform (N/A) |
|
Details | ||
| 12/30/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Neutral (N/A) |
|
Details | ||
| 12/13/2024 | Dyne Therapeutics | DYN | New Coverage | Outperform (N/A) |
27.47 (20.61) |
-24.97% | Details | |
| 12/13/2024 | Benitec BioPharma | BNTC | New Coverage | Outperform (N/A) |
13.08 (13.00) |
-0.61% | Details | |
| 12/2/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (Outperform) |
|
Details | ||
| 12/2/2024 | Applied Therapeutics | APLT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/29/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/29/2024 | Applied Therapeutics | APLT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/26/2024 | Enanta Pharmaceuticals | ENTA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (Outperform) |
|
Details | ||
| 11/15/2024 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2024 | Mirum Pharamceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2024 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 10/31/2024 | Alumis Inc | ALMS | New Coverage | Outperform (N/A) |
12.16 (25.03) |
105.84% | Details | |
| 10/24/2024 | Marinus Pharmaceuticals | MRNS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/23/2024 | Alto Neuroscience | ANRO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/7/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/27/2024 | Enanta Pharmaceuticals | ENTA | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/25/2024 | Biogen | BIIB | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/25/2024 | Amgen | AMGN | Maintain | Underperform (Underperform) |
|
Details | ||
| 9/24/2024 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/23/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/19/2024 | Applied Therapeutics | APLT | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/10/2024 | Alto Neuroscience | ANRO | Maintain | Outperform (Outperform) |
|
Details | ||
| 9/6/2024 | Nurix | NRIX | New Coverage | Outperform (N/A) |
24.69 (22.46) |
-9.03% | Details | |
| 8/8/2024 | Mirum Pharamceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2024 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2024 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/24/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/21/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/20/2024 | Alto Neuroscience | ANRO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/20/2024 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 6/17/2024 | Mirum Pharamceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 6/13/2024 | Lexeo Therapeutics | LXEO | New Coverage | Outperform (N/A) |
17.58 (4.70) |
-73.27% | Details | |
| 5/23/2024 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2024 | Soleno Therapeutics Inc. | SLNO | New Coverage | Outperform (N/A) |
46.26 (53.01) |
14.59% | Details | |
| 4/16/2024 | Marinus Pharmaceuticals | MRNS | Downgrade | Neutral (Outperform) |
7.52 (0.55) |
-92.69% | Details | |
| 4/15/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2024 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/29/2024 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2024 | Alto Neuroscience | ANRO | New Coverage | Outperform (N/A) |
13.72 (25.30) |
84.4% | Details | |
| 2/20/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2024 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/8/2024 | Enanta Pharmaceuticals | ENTA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2024 | Amgen | AMGN | Maintain | Underperform (N/A) |
|
Details | ||
| 2/5/2024 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 1/31/2024 | Vertex | VRTX | Downgrade | Neutral (Outperform) |
435.82 (480.18) |
10.18% | Details | |
| 1/8/2024 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/19/2023 | Mirum Pharamceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/14/2023 | Reneo Pharmaceuticals | RPHM | Downgrade | Neutral (Outperform) |
7.75 (1.82) |
-76.52% | Details | |
| 11/2/2023 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/1/2023 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2023 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/5/2023 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/3/2023 | Mirum Pharamceuticals | MIRM | Maintain | Outperform (N/A) |
|
Details | ||
| 9/26/2023 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/13/2023 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/11/2023 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2023 | Crinetics | CRNX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2023 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2023 | Reata Pharmaceuticals | RETA | Maintain | Neutral (N/A) |
|
Details | ||
| 6/28/2023 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 6/2/2023 | Regenxbio Inc. | RGNX | New Coverage | Outperform (N/A) |
17.23 (10.24) |
-40.57% | Details | |
| 5/22/2023 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2023 | Vertex | VRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/30/2023 | Crinetics | CRNX | New Coverage | Outperform (N/A) |
15.31 (34.99) |
128.54% | Details | |
| 3/24/2023 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2023 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Reata Pharmaceuticals | RETA | Maintain | Neutral (N/A) |
|
Details | ||
| 2/6/2023 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 1/10/2023 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2022 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/24/2022 | Myovant Sciences Ltd. | MYOV | Downgrade | Neutral (Outperform) |
24.54 (26.98) |
9.94% | Details | |
| 10/12/2022 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/3/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/28/2022 | Biogen | BIIB | Upgrade | Outperform (Neutral) |
195.75 (201.96) |
3.17% | Details | |
| 7/25/2022 | VistaGen Therapeutics | VTGN | Downgrade | Neutral (Outperform) |
0.15 (0.62) |
313.33% | Details | |
| 7/22/2022 | VistaGen Therapeutics | VTGN | Downgrade | Neutral (Outperform) |
1.07 (0.62) |
-42.06% | Details | |
| 2/10/2022 | Sio Gene Therapies | SIOX | New Coverage | Outperform (N/A) |
0.77 (0.42) |
-45.45% | Details | |
| 1/27/2022 | Reneo Pharmaceuticals | RPHM | New Coverage | Outperform (N/A) |
7.23 (1.82) |
-74.83% | Details | |
| 12/20/2021 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 12/9/2021 | Reata Pharmaceuticals | RETA | Downgrade | Neutral (Outperform) |
54.42 (172.36) |
216.72% | Details | |
| 12/6/2021 | Reata Pharmaceuticals | RETA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/7/2021 | Voyager Therapeutics | VYGR | Upgrade | Outperform (Neutral) |
3.87 (3.55) |
-8.27% | Details | |
| 9/24/2021 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 9/16/2021 | Theravance Biopharma | TBPH | Maintain | Neutral (N/A) |
|
Details | ||
| 8/24/2021 | Theravance Biopharma | TBPH | Maintain | Neutral (N/A) |
|
Details | ||
| 8/3/2021 | Immunovant | IMVT | Downgrade | Neutral (Outperform) |
10.46 (38.24) |
265.58% | Details | |
| 6/8/2021 | Biogen | BIIB | Upgrade | Neutral (Underperform) |
286.14 (201.96) |
-29.42% | Details | |
| 5/20/2021 | VistaGen Therapeutics | VTGN | New Coverage | Outperform (N/A) |
2.34 (0.62) |
-73.5% | Details | |
| 2/26/2021 | Voyager Therapeutics | VYGR | Downgrade | Neutral (Outperform) |
6.59 (3.55) |
-46.13% | Details | |
| 2/23/2021 | Vertex | VRTX | Upgrade | Outperform (Neutral) |
207.02 (480.18) |
131.95% | Details | |
| 11/10/2020 | Intercept Pharmaceuticals | ICPT | Upgrade | Outperform (Neutral) |
28.15 (19.00) |
-32.5% | Details | |
| 10/8/2020 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/8/2020 | Albireo Pharma | ALBO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/1/2020 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2020 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 8/18/2020 | Principia Biopharma | PRNB | Maintain | Outperform (N/A) |
|
Details | ||
| 7/23/2020 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 7/7/2020 | BELLUS Health Inc. | BLU | Maintain | Outperform (N/A) |
|
Details | ||
| 6/30/2020 | Intercept Pharmaceuticals | ICPT | Downgrade | Neutral (Outperform) |
77.49 (19.00) |
-75.48% | Details | |
| 6/29/2020 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 6/25/2020 | Mirum Pharamceuticals | MIRM | New Coverage | Outperform (N/A) |
20.97 (117.28) |
459.28% | Details | |
| 6/24/2020 | Albireo Pharma | ALBO | New Coverage | Outperform (N/A) |
27.50 (44.15) |
60.55% | Details | |
| 6/19/2020 | Biogen | BIIB | Maintain | Underperform (N/A) |
|
Details | ||
| 6/18/2020 | Biogen | BIIB | Maintain | Underperform (N/A) |
|
Details | ||
| 6/16/2020 | Applied Therapeutics | APLT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/12/2020 | Reata Pharmaceuticals | RETA | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/8/2020 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/22/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/21/2020 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 5/15/2020 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/29/2020 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 4/24/2020 | Principia Biopharma | PRNB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2020 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 4/17/2020 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 4/6/2020 | Voyager Therapeutics | VYGR | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2020 | Voyager Therapeutics | VYGR | Maintain | Outperform (N/A) |
|
Details | ||
| 3/31/2020 | Reata Pharmaceuticals | RETA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/31/2020 | Immunovant | IMVT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/17/2020 | Enanta Pharmaceuticals | ENTA | Upgrade | Outperform (Neutral) |
53.93 (13.45) |
-75.06% | Details | |
| 3/2/2020 | BELLUS Health Inc. | BLU | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2020 | Regeneron Pharma | REGN | Downgrade | Neutral (Outperform) |
425.38 (620.14) |
45.78% | Details | |
| 2/6/2020 | Biogen | BIIB | Maintain | Underperform (N/A) |
|
Details | ||
| 2/5/2020 | Biogen | BIIB | Maintain | Underperform (N/A) |
|
Details | ||
| 1/31/2020 | Vertex | VRTX | Downgrade | Neutral (Outperform) |
232.41 (480.18) |
106.61% | Details | |
| 1/31/2020 | Amgen | AMGN | Downgrade | Underperform (Neutral) |
227.15 (352.82) |
55.32% | Details | |
| 1/23/2020 | Biogen | BIIB | Maintain | Underperform (N/A) |
|
Details | ||
| 1/10/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/9/2020 | Applied Therapeutics | APLT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/8/2020 | Immunovant | IMVT | New Coverage | Outperform (N/A) |
15.57 (38.24) |
145.6% | Details | |
| 1/7/2020 | Apellis Pharmaceuticals | APLS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/20/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/17/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/2/2019 | Biogen | BIIB | Downgrade | Underperform (Neutral) |
303.35 (201.96) |
-33.42% | Details | |
| 11/25/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/12/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2019 | Theravance Biopharma | TBPH | Upgrade | Neutral (Underperform) |
17.03 (17.39) |
2.11% | Details | |
| 11/5/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2019 | Celgene | CELG | Downgrade | Neutral (Outperform) |
107.17 (108.24) |
1% | Details | |
| 10/21/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/15/2019 | Reata Pharmaceuticals | RETA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/11/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/4/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/30/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/18/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/16/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/9/2019 | Amgen | AMGN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/9/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/20/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/20/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2019 | Axovant Gene Therapies | AXGT | Upgrade | Outperform (Neutral) |
6.61 (2.10) |
-68.23% | Details | |
| 8/7/2019 | Assembly Biosciences | ASMB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Regeneron Pharma | REGN | Upgrade | Outperform (Neutral) |
299.57 (620.14) |
107.01% | Details | |
| 7/30/2019 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/26/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2019 | Applied Therapeutics | APLT | New Coverage | Outperform (N/A) |
9.10 (0.22) |
-97.58% | Details | |
| 6/6/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2019 | Amgen | AMGN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/10/2019 | Amgen | AMGN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/29/2019 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 3/28/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/21/2019 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 3/12/2019 | Celgene | CELG | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2019 | Voyager Therapeutics | VYGR | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/19/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2019 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 2/7/2019 | Regeneron Pharma | REGN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/1/2019 | Celgene | CELG | Maintain | Outperform (N/A) |
|
Details | ||
| 1/4/2019 | Celgene | CELG | Upgrade | Outperform (Neutral) |
66.64 (108.24) |
62.42% | Details | |
| 12/12/2018 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/7/2018 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2018 | Voyager Therapeutics | VYGR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2018 | Curis | CRIS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/25/2018 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 10/9/2018 | Principia Biopharma | PRNB | New Coverage | Outperform (N/A) |
26.37 (100.05) |
279.41% | Details | |
| 9/26/2018 | Reata Pharmaceuticals | RETA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/24/2018 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/12/2018 | Gilead Sciences | GILD | Maintain | Neutral (N/A) |
|
Details | ||
| 9/11/2018 | Amgen | AMGN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/10/2018 | Amgen | AMGN | Maintain | Neutral (N/A) |
|
Details |
